ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Josh Kesselman, HBI Innovations Founder, Featured in Article for the Huff Post

By: Newsfile

New York, New York--(Newsfile Corp. - September 16, 2025) -  Josh Kesselman, founder of HBI Innovations and RAW, was recently featured in an article for the Huff Post. The article focused on cannabis industry leaders' reactions to President Donald Trump's statement this week that his administration is "looking at" reclassifying marijuana under federal drug laws - a move that could represent one of the most significant shifts in cannabis policy in the U.S. in decades.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7768/266637_a01a5179f4518bd6_001.jpg

Josh Kesselman, founder of HBI Innovations, was recently featured in an article for the Huff Post. (Josh Kesselman founded HBI Innovations, the distributors of RAW rolling papers.)

During a Monday press conference, Trump said a decision could come within weeks on whether cannabis should move from its current Schedule I status to Schedule III, where it would sit alongside prescription drugs like steroids. Schedule I status is reserved for substances the government deems highly addictive and without accepted medical use.

For many in the cannabis industry, the comments sparked cautious optimism. Executives and advocates have long argued that rescheduling is overdue, as businesses and patients continue to operate in a legal gray area.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7768/266637_a01a5179f4518bd6_002.jpg


Josh Kesselman
was featured in the article along with other industry leaders. (Josh Kesselman founded HBI Innovations, the distributors of RAW rolling papers.)

Josh Kesselman was among the industry leaders interviewed for the Huff Post article. The HBI Innovations founder and publisher of High Times magazine called the possible move a "decent start," but cautioned that rescheduling does not go anywhere near far enough.

"As long as cannabis stays on the controlled substances list, people - especially those from over-policed communities - will be hit with the fallout, and the stigmas around cannabis won't change," Kesselman told Huff Post, "If we're serious about justice, business, and safe access, we need to deschedule entirely and build a system that doesn't just benefit the few."

For Kesselman, whose company HBI Innovations has built global recognition through brands like RAW® rolling papers, the message is clear: anything less than full rescheduling leaves the cannabis community vulnerable to the same inequities that have persisted for decades.

Read the full article here.

Contact: Alexa Oliphant
Email: alexa@mygrasslands.com
Website: https://rawthentic.com

Source: Grasslands

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266637

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.